CARE FAKEEH

Dr. Soliman Abdul Kader Fakeeh Hospital Co.

4017StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operating Summary
Revenue	724.15M	799.12M	778.26M	811.84M	701.02M
Cost of Revenue	584.25M	629.23M	601.01M	631.23M	524.88M
Gross Profit	139.90M	169.89M	177.25M	180.62M	176.14M
SG&A	93.41M	93.39M	101.20M	98.12M	93.63M
Operating Expenses	95.29M	94.61M	103.12M	99.01M	99.16M
Operating Income	44.61M	75.28M	74.13M	81.61M	76.98M
Interest Income	6.58M	3.44M	4.73M	5.41M	7.72M
Interest Expense	-17.18M	-14.81M	-14.10M	-10.01M	-9.93M
Pretax Income	34.01M	63.92M	64.76M	77.01M	74.78M
Income Tax	7.84M	8.42M	7.65M	8.85M	7.42M
Net Income	38.41M	64.22M	71.64M	82.12M	72.20M
EBITDA	78.39M	100.19M	107.84M	112.35M	103.29M
EBIT	44.61M	75.28M	74.13M	81.61M	76.98M
EPS (Basic)	0.17	0.28	0.31	0.36	0.31
EPS (Diluted)	0.17	0.28	0.31	0.36	0.31
Margins & Efficiency
Gross Margin %	+19.3%	+21.3%	+22.8%	+22.2%	+25.1%
EBITDA Margin %	+10.8%	+12.5%	+13.9%	+13.8%	+14.7%
Net Margin %	+5.3%	+8.0%	+9.2%	+10.1%	+10.3%
Revenue & Income
Revenue	724.15M	799.12M	778.26M	811.84M	701.02M
Revenue Growth (YoY)	+3.3%	+7.6%	+9.0%	+24.1%	+3.0%
Interest & Investment Income	6.58M	3.44M	4.73M	5.41M	7.72M
Gain (Loss) on Sale of Assets	—	—	—	—	—
Expenses & Provisions
Cost of Revenue	584.25M	629.23M	601.01M	631.23M	524.88M
Selling, General & Admin	93.41M	93.39M	101.20M	98.12M	93.63M
Operating Expenses	95.29M	94.61M	103.12M	99.01M	99.16M
Other Operating Expenses	-3.65M	-3.98M	-3.86M	-5.38M	-1.64M
Interest Expense	-17.18M	-14.81M	-14.10M	-10.01M	-9.93M
D&A For EBITDA	33.79M	24.91M	33.71M	30.74M	26.30M
Profitability & Returns
Gross Profit	139.90M	169.89M	177.25M	180.62M	176.14M
Gross Margin	+19.3%	+21.3%	+22.8%	+22.2%	+25.1%
EBIT	44.61M	75.28M	74.13M	81.61M	76.98M
EBIT Margin	+6.2%	+9.4%	+9.5%	+10.1%	+11.0%
EBITDA	78.39M	100.19M	107.84M	112.35M	103.29M
EBITDA Margin	+10.8%	+12.5%	+13.9%	+13.8%	+14.7%
EBT Excluding Unusual Items	34.01M	63.92M	64.76M	77.01M	74.78M
Pretax Income	34.01M	63.92M	64.76M	77.01M	74.78M
Operating Income	44.61M	75.28M	74.13M	81.61M	76.98M
Operating Margin	+6.2%	+9.4%	+9.5%	+10.1%	+11.0%
Profit Margin	+5.3%	+8.0%	+9.2%	+10.1%	+10.3%
Net Income	38.41M	64.22M	71.64M	82.12M	72.20M
Net Income to Common	38.41M	64.22M	71.64M	82.12M	72.20M
Net Income Growth	-46.8%	-13.0%	-23.5%	+73.0%	-0.7%
Earnings From Continuing Ops.	26.17M	55.49M	57.11M	68.16M	67.35M
Minority Interest in Earnings	12.25M	8.72M	14.53M	13.96M	4.85M
Income Tax Expense	7.84M	8.42M	7.65M	8.85M	7.42M
Effective Tax Rate	+23.1%	+13.2%	+11.8%	+11.5%	+9.9%
Per Share & Capital
EPS (Basic)	0.17	0.28	0.31	0.36	0.31
EPS (Diluted)	0.17	0.28	0.31	0.36	0.31
EPS Growth	-46.8%	-13.0%	-29.5%	+56.5%	-13.7%
Dividend Per Share	—	0.33	—	—	—
Shares Change (YoY)	—	0	0.09	0.11	0.15
Shares Outstanding (Basic)	230.00M	230.00M	231.11M	228.11M	230.00M
Shares Outstanding (Diluted)	230.00M	230.00M	231.11M	228.11M	230.00M
Dividend Growth	—	+10.0%	—	—	—
Free Cash Flow	-42.80M	128.97M	177.34M	-208.22M	-105.68M
Free Cash Flow Margin	-5.9%	+16.1%	+22.8%	-25.6%	-15.1%
Free Cash Flow Per Share	-0.19	0.56	0.77	-0.91	-0.46
Payout Ratio	—	—	+96.3%	—	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operating Summary
Revenue	724.15M	799.12M	778.26M	811.84M	701.02M
Cost of Revenue	584.25M	629.23M	601.01M	631.23M	524.88M
Gross Profit	139.90M	169.89M	177.25M	180.62M	176.14M
SG&A	93.41M	93.39M	101.20M	98.12M	93.63M
Operating Expenses	95.29M	94.61M	103.12M	99.01M	99.16M
Operating Income	44.61M	75.28M	74.13M	81.61M	76.98M
Interest Income	6.58M	3.44M	4.73M	5.41M	7.72M
Interest Expense	-17.18M	-14.81M	-14.10M	-10.01M	-9.93M
Pretax Income	34.01M	63.92M	64.76M	77.01M	74.78M
Income Tax	7.84M	8.42M	7.65M	8.85M	7.42M
Net Income	38.41M	64.22M	71.64M	82.12M	72.20M
EBITDA	78.39M	100.19M	107.84M	112.35M	103.29M
EBIT	44.61M	75.28M	74.13M	81.61M	76.98M
EPS (Basic)	0.17	0.28	0.31	0.36	0.31
EPS (Diluted)	0.17	0.28	0.31	0.36	0.31
Margins & Efficiency
Gross Margin %	+19.3%	+21.3%	+22.8%	+22.2%	+25.1%
EBITDA Margin %	+10.8%	+12.5%	+13.9%	+13.8%	+14.7%
Net Margin %	+5.3%	+8.0%	+9.2%	+10.1%	+10.3%
Revenue & Income
Revenue	724.15M	799.12M	778.26M	811.84M	701.02M
Revenue Growth (YoY)	+3.3%	+7.6%	+9.0%	+24.1%	+3.0%
Interest & Investment Income	6.58M	3.44M	4.73M	5.41M	7.72M
Gain (Loss) on Sale of Assets	—	—	—	—	—
Expenses & Provisions
Cost of Revenue	584.25M	629.23M	601.01M	631.23M	524.88M
Selling, General & Admin	93.41M	93.39M	101.20M	98.12M	93.63M
Operating Expenses	95.29M	94.61M	103.12M	99.01M	99.16M
Other Operating Expenses	-3.65M	-3.98M	-3.86M	-5.38M	-1.64M
Interest Expense	-17.18M	-14.81M	-14.10M	-10.01M	-9.93M
D&A For EBITDA	33.79M	24.91M	33.71M	30.74M	26.30M
Profitability & Returns
Gross Profit	139.90M	169.89M	177.25M	180.62M	176.14M
Gross Margin	+19.3%	+21.3%	+22.8%	+22.2%	+25.1%
EBIT	44.61M	75.28M	74.13M	81.61M	76.98M
EBIT Margin	+6.2%	+9.4%	+9.5%	+10.1%	+11.0%
EBITDA	78.39M	100.19M	107.84M	112.35M	103.29M
EBITDA Margin	+10.8%	+12.5%	+13.9%	+13.8%	+14.7%
EBT Excluding Unusual Items	34.01M	63.92M	64.76M	77.01M	74.78M
Pretax Income	34.01M	63.92M	64.76M	77.01M	74.78M
Operating Income	44.61M	75.28M	74.13M	81.61M	76.98M
Operating Margin	+6.2%	+9.4%	+9.5%	+10.1%	+11.0%
Profit Margin	+5.3%	+8.0%	+9.2%	+10.1%	+10.3%
Net Income	38.41M	64.22M	71.64M	82.12M	72.20M
Net Income to Common	38.41M	64.22M	71.64M	82.12M	72.20M
Net Income Growth	-46.8%	-13.0%	-23.5%	+73.0%	-0.7%
Earnings From Continuing Ops.	26.17M	55.49M	57.11M	68.16M	67.35M
Minority Interest in Earnings	12.25M	8.72M	14.53M	13.96M	4.85M
Income Tax Expense	7.84M	8.42M	7.65M	8.85M	7.42M
Effective Tax Rate	+23.1%	+13.2%	+11.8%	+11.5%	+9.9%
Per Share & Capital
EPS (Basic)	0.17	0.28	0.31	0.36	0.31
EPS (Diluted)	0.17	0.28	0.31	0.36	0.31
EPS Growth	-46.8%	-13.0%	-29.5%	+56.5%	-13.7%
Dividend Per Share	—	0.33	—	—	—
Shares Change (YoY)	—	0	0.09	0.11	0.15
Shares Outstanding (Basic)	230.00M	230.00M	231.11M	228.11M	230.00M
Shares Outstanding (Diluted)	230.00M	230.00M	231.11M	228.11M	230.00M
Dividend Growth	—	+10.0%	—	—	—
Free Cash Flow	-42.80M	128.97M	177.34M	-208.22M	-105.68M
Free Cash Flow Margin	-5.9%	+16.1%	+22.8%	-25.6%	-15.1%
Free Cash Flow Per Share	-0.19	0.56	0.77	-0.91	-0.46
Payout Ratio	—	—	+96.3%	—	—